Jana Partners Criticizes CNET's (CNET) Adoption of a Poison Pill
Tweet Send to a Friend
In an amended 13D filing on CNET Networks (Nasdaq: CNET), 12% holder Jana Partners disclosed a statement critizicing the company's ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
